TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.

Tempus AI (TEM) has recently secured FDA clearance for its Tempus ECG-Low EF software, an innovative AI-driven product aiding cardiovascular assessments. This development aligns with TEM’s aim to ...

Ghana’s Ministry of Energy has terminated 202 supply contracts of the Electricity Company of Ghana (ECG), valued at over ...

The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...

Philips (NYSE: PHG) today announced the launch of its new electrocardiogram (ECG) AI marketplace for cardiac care teams.

Benjamin Asare, Executive Director of the Centre for Environmental Management and Sustainability Energy, has voiced grave concern about the Electricity ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect individuals with a low left ...

A pediatric cardiologist has spoken out, explaining that she had to perform an emergency cesarean section after the woman's ...

The Minister for Energy and Green Transition, John Jinapor, has once again dismissed claims that the government intends to sell the Electricity Company of ...

With the help of artificial intelligence (AI), an inexpensive test found in many doctors' offices may soon be used to screen ...

This new AI heart disease detector can’t be beat. S (SHD) refers to defects in the heart’s valves, wall or chambers that are present at birth or develop ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday after the company announced that it received 510(k) clearance ...